Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Pharma sector needs protecting from Trump tariffs, warn MPs

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.


There are a large number of pharmaceutical companies based in Oxfordshire and the wider Thames Valley region.

"Trump’s trade war has already caused catastrophic damage and I’m particularly concerned about what possible pharmaceutical tariffs might mean,” said Glover, Liberal Democrat MP for Didcot and Wantage.

"Pharmaceutical industry jobs are especially important here in Oxfordshire, with Milton Park in my constituency being a crucial hub for pharmaceutical innovation.

"It is vital that they are protected."

Trump has enacted sweeping changes on a wide range of U.S. domestic and foreign policy priorities since taking office on January 20. He has upended the world economic order with tariffs, slashed the federal government with job cuts and done away with diversity programs in the public and private sector.

The president launched an all-out trade war on numerous countries this year before putting reciprocal tariffs largely on hold to allow for negotiations with individual nations. His administration hopes to secure agreements within 90 days.

The UK has pushed for a trade deal with the US in the hope that this could soften the impact of the Trump tariffs.

Trump's press secretary Karoline Leavitt said yesterday that trade talks were "moving in a very positive way".

The MPs' call comes as some companies that rely heavily on exports to the US are reportedly considering moving their manufacturing from the UK to America, according to RBC analysts.

"The life sciences sector needs a genuine industrial strategy to support growth and provide the conditions for growth, not just warm words from the government,” said van Mierlo, MP for Henley and Thame and chair of the All Party Parliamentary Group on Access to Medicines

"Manufacturing of advanced therapeutics should go alongside our thriving research and innovation sector.

"It is also vital that ministers take steps to reassure the public and prepare for every scenario that the chaotic Trump administration could force upon us."

Mierlo called for the creation of a government task force to help protect people and pharmaceutical companies, both nationally and in Oxfordshire.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less